Capstone Wealth Management Group, LLC Amgen Inc Transaction History

Capstone Wealth Management Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $32,965 - $40,179	-146 Reduced 13.98%	898 $217,000
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $15,803 - $20,079	-69 Reduced 6.2%	1,044 $0
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $21,323 - $24,049	-95 Reduced 7.86%	1,113 $251,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $9,459 - $10,526	-41 Reduced 3.28%	1,208 $294,000
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $4,823 - $5,336	-22 Reduced 1.73%	1,249 $302,000
Q4 2021 Apr 12, 2022	BUY	$198.88 - $227.6 $252,776 - $289,279	1,271 New	1,271 $286,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Capstone Wealth Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Wealth Management Group, LLC with notifications on news.